Lake Forest, IL, United States of America

Honorats A Stelmach

This inventor holds 1 USPTO granted patent. Top assignee: Abbott Laboratories Corporation. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Honorats A Stelmach. Retrieved from https://idiyas.com/inventor/honorats-a-stelmach

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Honorats A Stelmach: Innovator in Anesthetic Compositions

Introduction

Honorats A Stelmach is a notable inventor based in Lake Forest, IL (US). He has made significant contributions to the field of anesthetic compositions, particularly through his innovative patent. His work focuses on enhancing the stability of fluoroether compounds in the presence of Lewis acids.

Latest Patents

Stelmach holds a patent for "Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid." This invention relates to an anesthetic composition that includes a fluoroether compound and a physiologically acceptable Lewis acid inhibitor. The composition demonstrates improved stability and does not readily degrade when exposed to a Lewis acid.

Career Highlights

Honorats A Stelmach is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to contribute to advancements in anesthetic formulations, showcasing his expertise in chemical compositions.

Collaborations

Some of his coworkers include Christopher Bieniarz and Steve H Chang, who have collaborated with him on various projects within the company.

Conclusion

Honorats A Stelmach's innovative work in anesthetic compositions highlights his role as a significant contributor to the field. His patent reflects a commitment to improving medical formulations and enhancing patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…